An Integrative Transcriptome Subtraction Strategy to Identify Human lncRNAs That Specifically Play a Role in Activation of Human Hepatic Stellate Cells
Non-Coding RNA · 06.06.2024 · 10 (3) · 34
DOI: 10.3390/ncrna10030034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Non-Coding RNA, online erschienen am 06.06.2024. Verfasst von Yonghe Ma und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Intramural NIH HHS, NIH HHS, NHLBI Division of Intramural Research funds.
Abstract (Originalsprache)
Fibrotic liver features excessive deposition of extracellular matrix (ECM), primarily produced from “activated” hepatic stellate cells (HSCs). While targeting human HSCs (hHSCs) in fibrosis therapeutics shows promise, the overall understanding of hHSC activation remains limited, in part because it is very challenging to define the role of human long non-coding RNAs (lncRNAs) in hHSC activation. To address this challenge, we identified another cell type that acts via a diverse gene network to promote fibrogenesis. Then, we identified the lncRNAs that were differentially regulated in activated hHSCs and the other profibrotic cell. Next, we conducted concurrent analysis to identify those lncRNAs that were specifically involved in fibrogenesis. We tested and confirmed that transdifferentiation of vascular smooth muscle cells (VSMCs) represents such a process. By overlapping TGFβ-regulated lncRNAs in multiple sets of hHSCs and VSMCs, we identified a highly selected list of lncRNA candidates that could specifically play a role in hHSC activation. We experimentally characterized one human lncRNA, named CARMN, which was significantly regulated by TGFβ in all conditions above. CARMN knockdown significantly reduced the expression levels of a panel of marker genes for hHSC activation, as well as the levels of ECM deposition and hHSC migration. Conversely, gain of function of CARMN using CRISPR activation (CRISPR-a) yielded the completely opposite effects. Taken together, our work addresses a bottleneck in identifying human lncRNAs that specifically play a role in hHSC activation and provides a framework to effectively select human lncRNAs with significant pathophysiological role.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiovascular Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.
ORCID-Profile: Yonghe Ma, Jamie Harris
Förderung
- Intramural NIH HHS
- NIH HHS
- NHLBI Division of Intramural Research funds
Zitieren
APA
Ma, Y., Harris, J., Li, P., Jiang, C., Sun, H., & Cao, H. (2024). An Integrative Transcriptome Subtraction Strategy to Identify Human lncRNAs That Specifically Play a Role in Activation of Human Hepatic Stellate Cells. Non-Coding RNA, 10(3), 34. https://doi.org/10.3390/ncrna10030034
Vancouver
Ma Y, Harris J, Li P, Jiang C, Sun H, Cao H. An Integrative Transcriptome Subtraction Strategy to Identify Human lncRNAs That Specifically Play a Role in Activation of Human Hepatic Stellate Cells. Non-Coding RNA. 2024;10(3):34. doi:10.3390/ncrna10030034
BibTeX
@article{Ma2024,
author = {Ma, Yonghe and Harris, Jamie and Li, Ping and Jiang, Chengfei and Sun, Hang and Cao, Haiming},
title = {An Integrative Transcriptome Subtraction Strategy to Identify Human lncRNAs That Specifically Play a Role in Activation of Human Hepatic Stellate Cells},
journal = {Non-Coding RNA},
year = {2024},
volume = {10},
number = {3},
pages = {34},
doi = {10.3390/ncrna10030034}
}
EUVIMED